Ring Christine bought NRIX
October 2, 2026 · Form 4 insider transaction
Ring Christine bought 5,786 shares of Nurix Therapeutics, Inc. at $8.72 per share, a transaction worth $50.5K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,786
Price
$8.72
Total value
$50.5K
InsiderRing Christine
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateOctober 2, 2026
Filing dateOctober 2, 2026
Shares owned after14,896
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.